{"product_id":"arvenum-500-mg-30-compresse-rivestite","title":"Arvenum 500 mg 30 coated tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptoms attributable to venous insufficiency; states of capillary fragility Symptomatic treatment of acute hemorrhoidal crisis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach film-coated tablet contains 500 mg of micronized purified flavonoid fraction consisting of 450 mg of diosmin and 50 mg of flavonoids expressed as hesperidin. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium starch starch, microcrystalline cellulose, gelatin, glycerin, hypromellose, sodium lauryl sulphate, yellow iron oxide E 172, red iron oxide E 172, titanium dioxide, macrogol 6000, magnesium stearate, talc.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage \u003ci\u003eVenous insufficiency (also of the haemorrhoidal plexus) and capillary fragility \u003c\/i\u003e The recommended dose is 2 tablets to be taken in two doses per day. Do not exceed the maximum daily dose. \u003ci\u003eAcute hemorrhoidal crisis\u003c\/i\u003e The recommended dose is 3 tablets twice a day during the first 4 days of treatment; in the following 3 days the daily dose is 4 tablets in 2 administrations. Do not exceed the maximum daily dose. Method of administration Take the tablets with the two main meals. Duration of treatment Treatment must not be continued beyond 7 days. In the absence of a therapeutic response, reassess the situation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImportant information about some excipients Arvenum contains less than 1 mmol (23 mg) sodium per tablet, i.e. it is essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interaction studies have been performed. To date, no clinically relevant drug interactions have been reported from post-marketing experience on the product.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following adverse effects or reactions have been reported and are classified according to the following frequency: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000), not known (frequency cannot be estimated from the available data). \u003ci\u003eNervous system disorders\u003c\/i\u003e Rare: dizziness, headache, malaise \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e Common: diarrhoea, dyspepsia, nausea, vomiting Uncommon: colitis Not known: abdominal pain \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Rare: rash, pruritus, urticaria Not known: edema of the face, lips, eyelid; Quincke's edema \u003ci\u003ePathologies of the blood and lymphatic system\u003c\/i\u003e Not known: thrombocytopenia \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the risk\/benefit ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptoms There is limited experience with Arvenum overdose. The most frequently reported adverse events in cases of overdose were gastrointestinal events (such as diarrhea, nausea, abdominal pain) and skin events (such as pruritus, rash). Management Management of overdose should consist of treatment of clinical symptoms.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e Data relating to the use of purified micronized flavonoid fraction in pregnant women do not exist or are limited in number. Animal studies do not indicate reproductive toxicity (see section 5.3). As a precaution, it is preferable to avoid the use of Arvenum during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e It is not known whether the active substance\/metabolites are excreted in breast milk. A risk to the newborn\/infants cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue\/abstain from Arvenum therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman. \u003cu\u003eFertility\u003c\/u\u003e Reproductive toxicity studies have shown no effects on fertility in either male or female rats (see section 5.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies have been conducted to evaluate the effect of the flavonoid fraction on the ability to drive or use machinery.\u003c\/p\u003e","brand":"Stroder","offers":[{"title":"Default Title","offer_id":51730203279687,"sku":"024552022","price":17.8,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/stroder-arvenum-500-mg-30-compresse-rivestite-farmacia-dottor-tili-1254211100.jpg?v=1786730185","url":"https:\/\/www.dottortili.com\/en-eu\/products\/arvenum-500-mg-30-coated-tablets","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}